YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Advanced Enzyme Technologies

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 16, 16:00
414.45
2.6 (0.63%)
VOLUME 36,247
LIVE
NSE
Jun 16, 15:59
414.45
2.7 (0.66%)
VOLUME 247,225
News on Advanced Enzyme Technologies
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Advanced Enzymes: Niche business available at attractive valuations makes it a strong buy

8.56 am | 22 Sep 2018 |  Source: Moneycontrol.com

Post the Q1 results, the management has maintained its guidance for a topline of Rs 440-450 crores along with an operational profit of 190-200 crore. ...

1
Quick Links for Advanced Enzyme Technologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.